Tag: generic drug supply chain
Chinese factories produce 78% of the world's generic drug ingredients, keeping prices low but raising serious quality concerns. FDA inspections reveal widespread failures in testing, data integrity, and manufacturing control - putting patient safety at risk.
Medications
Archives
Recent-posts
Why Lupus Support Groups Matter for Discoid and Systemic Lupus Patients
Oct, 17 2025
Risk-Benefit Statements in FDA Labels: What Patients Need to Know
Feb, 11 2026
Deficiency Letters in Generic Drug Applications: Common FDA Findings and How to Avoid Them
Jan, 16 2026
Black Box Warnings: What You Need to Know About the FDA’s Strongest Drug Safety Alerts
Nov, 19 2025
Generic Drug Contamination Risks: How to Prevent and Respond to Unsafe Medications
Nov, 14 2025